Life-long diseases need life-long treatment: long-term safety of ciclosporin in canine atopic dermatitis. - Wikidata - awgldk - TriplyDB

Life-long diseases need life-long treatment: long-term safety of ciclosporin in canine atopic dermatitis.

Life-long diseases need life-long treatment: long-term safety of ciclosporin in canine atopic dermatitis.

http://www.wikidata.org/entity/Q38200540

about

Gonadectomy effects on the risk of immune disorders in the dog: a retrospective study.Repeated oral dose tolerance in dogs treated concomitantly with ciclosporin and oclacitinib for three weeks Ciclosporin 10 years on: indications and efficacy.Voluntary acceptance and consumption of two oral ciclosporin formulations in dogs: two randomised, controlled studies Comparison of the stability and pharmacokinetics in dogs of modified ciclosporin capsules stored at -20°C and room temperature.A blinded, randomized clinical trial evaluating the efficacy and safety of lokivetmab compared to ciclosporin in client-owned dogs with atopic dermatitis.Developments in small animal veterinary dermatology.Atopic dermatitis in cats and dogs: a difficult disease for animals and owners

P2860

Q33437476-73A980DD-3EDA-4B2F-A4ED-96E8CD522916 Q36533132-B4E462C3-83CB-4ADC-A5DA-1C8911D5C09B Q38200541-D13970DF-2D67-4AE7-A1E2-109B52EECC6B Q41825444-ED532EF6-75D7-4DF9-AA34-550928321EBA Q48158348-593B3123-21AC-4167-B238-9F9D9A9144E2 Q48347863-9FE03868-2522-48EE-BE5F-CD806AA73707 Q50185658-4378C9CB-D607-4CC5-8DCB-1F46CA8D6D5A Q57482859-80B37A68-2616-4156-A529-E194F03E6FE1

P2860

Life-long diseases need life-long treatment: long-term safety of ciclosporin in canine atopic dermatitis.

http://www.wikidata.org/entity/Q38200540

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Life-long diseases need life-l ...... n in canine atopic dermatitis.

@en

type

label

Life-long diseases need life-l ...... n in canine atopic dermatitis.

@en

prefLabel

Life-long diseases need life-l ...... n in canine atopic dermatitis.

@en

P1433

Q38200540-0EFA2F51-51C6-460E-9CB0-ADF3153A640D

P1476

Q38200540-4E5D176E-CA5E-4720-811C-C5EB225F715F

P2093

Q38200540-51D3693D-68EB-4103-B0BC-046D2D70BD49

Q38200540-90C47500-3722-4AE7-B40B-46EFECAD0BCD

Q38200540-A44441E2-67D0-4FAD-8632-0BBDB4D5BC70

P275

Q38200540-5C2031D4-F311-4BDA-865C-AAEDCC04BF31

P2860

Q38200540-03C1AC50-43CF-4459-8AB7-C4E3AA462A34

Q38200540-0C9C1C5E-6080-49ED-B108-3A82172A7B4B

Q38200540-0FE5D0A7-9965-400D-8564-C85453DA0C7C

Q38200540-20B3F203-4982-447C-A002-CA3760094BEC

Q38200540-2856DCC9-37AF-4D54-8565-1CE7F7B2124A

Q38200540-325DD34B-BD67-4D63-A82B-8F79AC249058

Q38200540-3F0762DD-5148-44DE-A604-2BC414B388DA

Q38200540-3F4B014E-6B0A-414A-B1F5-671DE80573AD

Q38200540-47B9ED5D-DE90-46FD-8356-835440583F68

Q38200540-4D497B95-7C5E-4FA1-A899-635B3AEDB6D7

P304

Q38200540-FB223371-65FA-4FA5-BEDB-5E70DD93454C

P31

Q38200540-9C69BE79-A07C-4B30-9437-2ED908C55EC8

Q38200540-9D0D92DC-0670-4774-B280-0630B638DC94

P356

Q38200540-2B7EAAFB-7AB4-4FE7-BF99-D25327A48799

P407

Q38200540-8327CCCA-A304-46A9-A299-ABBCE262EBBC

P478

Q38200540-3109B5C4-476C-4ABF-A9EE-4F25F22C7044

P5008

Q38200540-8638A04F-CC6F-4575-9B54-D1D064EE73BA

P577

Q38200540-143D9AE5-7491-473E-A71E-1E525EB14BE8

P5875

Q38200540-78A610DA-1D96-4C43-AC0E-0F79519E727D

P698

Q38200540-3642C2D8-3A39-4906-B19B-8014F31A961E

P921

Q38200540-3EC794F7-D3E5-42B9-8155-5118BD3755F0

Q38200540-5EA7ACAD-6CA7-4A58-ABA9-9C820107E270

Q38200540-72C246B4-232B-4DE6-8421-B65C8467A4C8

P932

Q38200540-6B982460-E07E-46B4-948D-F5A2826643D8

P356

P1433

Veterinary Record

P1476

Life-long diseases need life-l ...... n in canine atopic dermatitis.

@en

P2093

Douglas Reece

http://www.w3.org/2001/XMLSchema#string

Elizabeth Roberts

http://www.w3.org/2001/XMLSchema#string

Tim Nuttall

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Evidence-based veterinary dermatology: a systematic review of the pharmacotherapy of canine atopic dermatitis

Cyclosporin A: a new drug in the field of canine dermatology

The effects of cyclosporine versus standard care in dogs with naturally occurring glomerulonephritis.

Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition.

Neurotoxicity of calcineurin inhibitors: impact and clinical management.

Cyclosporine and tacrolimus in dermatology.

Cyclosporine in veterinary dermatology.

Calcineurin inhibitors and rapamycin: cancer protection or promotion?

Concurrent short-term use of prednisolone with cyclosporine A accelerates pruritus reduction and improvement in clinical scoring in dogs with atopic dermatitis

Cyclosporin: applications in small animal dermatology.

P304

3-12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/VR.102471

http://www.w3.org/2001/XMLSchema#string

P407

P478

174 Suppl 2

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2014-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261221673

http://www.w3.org/2001/XMLSchema#string

P698

24682696

http://www.w3.org/2001/XMLSchema#string

P921

atopic dermatitis

polycyclic compound

P932

3995266

http://www.w3.org/2001/XMLSchema#string